Dr Stephanie Wain, MD - Medicare Pathology in Derby, CT

Dr Stephanie Wain, MD is a medicare enrolled "Pathology - Anatomic Pathology & Clinical Pathology" physician in Derby, Connecticut. She graduated from medical school in 2015 and has 9 years of diverse experience with area of expertise as Pathology. She is a member of the group practice Griffin Pathology Consultants, P.c. and her current practice location is 130 Division St, Derby, Connecticut. You can reach out to her office (for appointments etc.) via phone at (203) 732-7285.

Dr Stephanie Wain is licensed to practice in Connecticut (license number 029076) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1710027040.

Contact Information

Dr Stephanie Wain, MD
130 Division St,
Derby, CT 06418-1326
(203) 732-7285
(203) 732-7187



Physician's Profile

Full NameDr Stephanie Wain
GenderFemale
SpecialityPathology
Experience9 Years
Location130 Division St, Derby, Connecticut
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Stephanie Wain graduated from medical school in 2015
  NPI Data:
  • NPI Number: 1710027040
  • Provider Enumeration Date: 02/07/2007
  • Last Update Date: 07/08/2007
  Medicare PECOS Information:
  • PECOS PAC ID: 9032263314
  • Enrollment ID: I20110115000050

Medical Identifiers

Medical identifiers for Dr Stephanie Wain such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1710027040NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207ZP0102XPathology - Anatomic Pathology & Clinical Pathology 029076 (Connecticut)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Griffin HospitalDerby, CTHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Griffin Pathology Consultants, P.c.87291305212

News Archive

Researchers create detailed blueprints of molecular moving vans that transport zinc everywhere

Zinc is essential for wound healing, for vision, for DNA creation, for our senses of taste and smell, even for sexual health. But despite its importance, scientists have never fully understood the mechanism that moves the mineral through the body - until now.

Hodgkin's lymphoma treatment can cause late sequelae

Hodgkin's lymphoma-cancer of the lymph nodes-arises in more than 150 children and adolescents in Germany each year. Nine out of ten patients survive the disease, thanks to the highly effective treatments that are now available. Depending on the type of treatment given, however, there may be late sequelae, as discussed by Wolfgang Dörffel and colleagues in an original article in the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2015; 112: 320-7).

The ThermoDox and MR-HIFU program shows great promise for treating life-threatening cancers

Royal Philips Electronics (NYSE: PHG; AEX: PHI) and Celsion Corporation (NASDAQ: CLSN) today announced that their joint research program to evaluate ThermoDox® in combination with MR-HIFU (Magnetic Resonance guided High Intensity Focused Ultrasound) as a combination therapy to non-invasively treat difficult cancers has successfully completed the feasibility stage.

Metabolic imbalance in cancer patients associated with resistance to immune checkpoint blocker

A metabolic imbalance in some cancer patients following treatment with a checkpoint inhibitor drug, nivolumab, is associated with resistance to the immunotherapy agent and shorter survival, report scientists from Dana-Farber Cancer Institute, in collaborative work with the Broad Institute of MIT and Harvard.

Read more Medical News

› Verified 1 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Stephanie Wain allows following entities to bill medicare on her behalf.
Entity NameGriffin Pathology Consultants, P.c.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1801934484
PECOS PAC ID: 8729130521
Enrollment ID: O20090820000721

News Archive

Researchers create detailed blueprints of molecular moving vans that transport zinc everywhere

Zinc is essential for wound healing, for vision, for DNA creation, for our senses of taste and smell, even for sexual health. But despite its importance, scientists have never fully understood the mechanism that moves the mineral through the body - until now.

Hodgkin's lymphoma treatment can cause late sequelae

Hodgkin's lymphoma-cancer of the lymph nodes-arises in more than 150 children and adolescents in Germany each year. Nine out of ten patients survive the disease, thanks to the highly effective treatments that are now available. Depending on the type of treatment given, however, there may be late sequelae, as discussed by Wolfgang Dörffel and colleagues in an original article in the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2015; 112: 320-7).

The ThermoDox and MR-HIFU program shows great promise for treating life-threatening cancers

Royal Philips Electronics (NYSE: PHG; AEX: PHI) and Celsion Corporation (NASDAQ: CLSN) today announced that their joint research program to evaluate ThermoDox® in combination with MR-HIFU (Magnetic Resonance guided High Intensity Focused Ultrasound) as a combination therapy to non-invasively treat difficult cancers has successfully completed the feasibility stage.

Metabolic imbalance in cancer patients associated with resistance to immune checkpoint blocker

A metabolic imbalance in some cancer patients following treatment with a checkpoint inhibitor drug, nivolumab, is associated with resistance to the immunotherapy agent and shorter survival, report scientists from Dana-Farber Cancer Institute, in collaborative work with the Broad Institute of MIT and Harvard.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Stephanie Wain is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Stephanie Wain, MD
44 Hampton Close,
Orange, CT 06477-1933

Ph: (203) 799-6122
Dr Stephanie Wain, MD
130 Division St,
Derby, CT 06418-1326

Ph: (203) 732-7285

News Archive

Researchers create detailed blueprints of molecular moving vans that transport zinc everywhere

Zinc is essential for wound healing, for vision, for DNA creation, for our senses of taste and smell, even for sexual health. But despite its importance, scientists have never fully understood the mechanism that moves the mineral through the body - until now.

Hodgkin's lymphoma treatment can cause late sequelae

Hodgkin's lymphoma-cancer of the lymph nodes-arises in more than 150 children and adolescents in Germany each year. Nine out of ten patients survive the disease, thanks to the highly effective treatments that are now available. Depending on the type of treatment given, however, there may be late sequelae, as discussed by Wolfgang Dörffel and colleagues in an original article in the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2015; 112: 320-7).

The ThermoDox and MR-HIFU program shows great promise for treating life-threatening cancers

Royal Philips Electronics (NYSE: PHG; AEX: PHI) and Celsion Corporation (NASDAQ: CLSN) today announced that their joint research program to evaluate ThermoDox® in combination with MR-HIFU (Magnetic Resonance guided High Intensity Focused Ultrasound) as a combination therapy to non-invasively treat difficult cancers has successfully completed the feasibility stage.

Metabolic imbalance in cancer patients associated with resistance to immune checkpoint blocker

A metabolic imbalance in some cancer patients following treatment with a checkpoint inhibitor drug, nivolumab, is associated with resistance to the immunotherapy agent and shorter survival, report scientists from Dana-Farber Cancer Institute, in collaborative work with the Broad Institute of MIT and Harvard.

Read more News

› Verified 1 days ago


Pathology Doctors in Derby, CT

Dr. James E. Haswell, M.D.
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 130 Division St, Laboratory, Griffin Hospital, Derby, CT 06418
Phone: 203-732-7284    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.